Private equity’s role in the health-care industry is a hot topic among US antitrust regulators—both federal regulators and state enforcers are focused on whether and how private equity ownership impacts quality and availability of care.
State and federal legislators are also taking note, introducing legislation aimed at curbing what some see as the risk of permitting the private equity business model to expand in the health-care industry.
A bill introduced this week in the US Senate, and one pending before the California senate, demonstrate the primary government concerns about ownership in health care. Regardless of the outcome of these specific ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.